Joint trials of Sputnik V vaccine and AstraZeneca started


Russian anti-COVID-19 vaccine Sputnik V developers and the British-Swedish vaccine AstraZeneca started joint clinical trials, Russian vaccine’s Twitter account reports.

“The use of the Sputnik V vaccine along with AstraZeneca eliminates the need to wait 3 months for the second injection”, the report said.

The report also indicates that the developers of Sputnik V offered cooperation to the creators of other vaccines with an efficiency of less than 90%.